The expression frequency of BrdU-induced fragile sites was examined in schizophrenia patients to determine whether this parameter could be used as a marker of genetic susceptibility in at-risk individuals. No difference was found in expression frequen...
The expression frequency of BrdU-induced fragile sites was examined in schizophrenia patients to determine whether this parameter could be used as a marker of genetic susceptibility in at-risk individuals. No difference was found in expression frequency between the schizophrenia patients and a group of normal individuals. This indicates that the expression frequency of bromodeoxyuridine induced fragile sites is not a suitable marker for assessing genetic susceptibility in schizophrenia.